American Health Packaging Azithromycin tablets, USP 250mg recall — FDA D-1223-2015
CGMP Deviations: Firm did not adequately investigate customer complaints.
Browse U.S. drug recall enforcement reports from the FDA in a structured, searchable format. Review the recalled product, reason, firm, status, dates, distribution information and FDA classification when available.
10,690 detailed records are currently available in this category.
CGMP Deviations: Firm did not adequately investigate customer complaints.
Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)
Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)
Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)
Subpotent Drug: menthol and methyl salicylate below specification
Failed Content Uniformity Specifications: Failed Uniformity of Dosage Units specifications.
CGMP Deviations: Firm did not adequately investigate customer complaints.
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
CGMP Deviations: Firm did not adequately investigate customer complaints.
Lack of Assurance of Sterility: Sterility of product is not assured.
Lack of Assurance of Sterility: Sterility of product is not assured.
Superpotent Drug: Confirmed customer complaint of a single unit dose blister cavity containing 2 OXYCODONE HCl 5 mg tablets.
Lack of Assurance of Sterility: Sterility of product is not assured.
Lack of Assurance of Sterility: Sterility of product is not assured.
Lack of Assurance of Sterility: Sterility of product is not assured.
Lack of Assurance of Sterility: Sterility of product is not assured.
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.